Operating Income
Operating Income
United Therapeutics Operating Income decreased by 8.7% to $325.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.9%, from $382.80M to $325.80M. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 28.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Detailed definition
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
Peer comparison
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
Metric ID:
operating_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $222.20M | $228.70M | $169.80M | $288.00M | $201.80M | $314.30M | $175.60M | $284.40M | $313.40M | $327.00M | $260.10M | $356.30M | $319.90M | $343.10M | $357.70M | $382.80M | $364.50M | $388.50M | $356.70M | $325.80M |
| QoQ Change | — | +2.9% | -25.8% | +69.6% | -29.9% | +55.7% | -44.1% | +62.0% | +10.2% | +4.3% | -20.5% | +37.0% | -10.2% | +7.3% | +4.3% | +7.0% | -4.8% | +6.6% | -8.2% | -8.7% |
| YoY Change | — | — | — | — | -9.2% | +37.4% | +3.4% | -1.3% | +55.3% | +4.0% | +48.1% | +25.3% | +2.1% | +4.9% | +37.5% | +7.4% | +13.9% | +13.2% | -0.3% | -14.9% |
Range$169.80M – $388.50M
CAGR+8.4%
Avg YoY Growth+14.2%
Median YoY Growth+6.2%
Current Streak2 quarters decline
Operating Income at Other Companies
Frequently Asked Questions
- What is United Therapeutics's operating income?
- United Therapeutics (UTHR) reported operating income of $325.80M in Q1 2026.
- How has United Therapeutics's operating income changed year-over-year?
- United Therapeutics's operating income decreased by 14.9% year-over-year, from $382.80M to $325.80M.
- What is the long-term trend for United Therapeutics's operating income?
- Over 4 years (2021 to 2025), United Therapeutics's operating income has grown at a 28.0% compound annual growth rate (CAGR), from $555.90M to $1.49B.
- What does operating income mean?
- The profit a company makes from its core business operations before interest and taxes.